1. Home
  2. ACET vs GOCO Comparison

ACET vs GOCO Comparison

Compare ACET & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • GOCO
  • Stock Information
  • Founded
  • ACET 1947
  • GOCO 2001
  • Country
  • ACET United States
  • GOCO United States
  • Employees
  • ACET N/A
  • GOCO N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • GOCO Specialty Insurers
  • Sector
  • ACET Health Care
  • GOCO Finance
  • Exchange
  • ACET Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • ACET 61.2M
  • GOCO 64.9M
  • IPO Year
  • ACET N/A
  • GOCO 2020
  • Fundamental
  • Price
  • ACET $0.76
  • GOCO $5.89
  • Analyst Decision
  • ACET Buy
  • GOCO Hold
  • Analyst Count
  • ACET 6
  • GOCO 1
  • Target Price
  • ACET $6.00
  • GOCO $18.00
  • AVG Volume (30 Days)
  • ACET 406.7K
  • GOCO 68.5K
  • Earning Date
  • ACET 08-12-2025
  • GOCO 08-07-2025
  • Dividend Yield
  • ACET N/A
  • GOCO N/A
  • EPS Growth
  • ACET N/A
  • GOCO N/A
  • EPS
  • ACET N/A
  • GOCO N/A
  • Revenue
  • ACET N/A
  • GOCO $834,266,000.00
  • Revenue This Year
  • ACET N/A
  • GOCO $8.51
  • Revenue Next Year
  • ACET N/A
  • GOCO $7.19
  • P/E Ratio
  • ACET N/A
  • GOCO N/A
  • Revenue Growth
  • ACET N/A
  • GOCO 13.18
  • 52 Week Low
  • ACET $0.45
  • GOCO $5.01
  • 52 Week High
  • ACET $1.70
  • GOCO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • ACET 57.89
  • GOCO 49.32
  • Support Level
  • ACET $0.58
  • GOCO $5.61
  • Resistance Level
  • ACET $0.82
  • GOCO $6.21
  • Average True Range (ATR)
  • ACET 0.04
  • GOCO 0.35
  • MACD
  • ACET 0.01
  • GOCO 0.06
  • Stochastic Oscillator
  • ACET 74.79
  • GOCO 53.54

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: